$NAVB Company News Navidea Biopharmaceuticals falls 8%

New Post Public Reply Private Reply Replies (0) Message Board

Jun 8, 2014 at 11:34 AM

$NAVB Company News

Navidea Biopharmaceuticals falls 8% in premarket 8:51 a.m. Dec. 3, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:55 p.m. Sept. 18, 2012 - MarketWatch
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Navidea Biopharmaceuticals down 32% in premarket 8:47 a.m. Sept. 11, 2012 - Steve Gelsi
Hot stocks to watch 7:32 a.m. Sept. 11, 2012 - MarketWatch.com
Stocks to watch Tuesday: Sonoco, Navidea, Thor 6:58 a.m. Sept. 11, 2012 - MarketWatch
Shuffle Master, Navidea shares drop after hours 5:59 p.m. Sept. 10, 2012 - Carla Mozee
Navidea shares slide 37% in trading after hours 4:29 p.m. Sept. 10, 2012 - Carla Mozee
In focus: Gathering strength 7:23 p.m. July 11, 2012 - Lawrence G. McMillan
Tuesday’s biggest gaining and declining stocks 5:16 p.m. April 3, 2012 - Kate Gibson

Sweet transition for Navidea CEO 7:04 p.m. June 2, 2014 - Seeking Alpha
2nd Half Of 2014 Biotechnology Catalysts: Part 1 9:34 a.m. May 27, 2014 - Seeking Alpha
Leadership changes at Navidea 7:29 a.m. May 19, 2014 - Seeking Alpha
We Are Continuing To See Strong Growth In Sales, Says Navidea CFO 2:32 p.m. May 14, 2014 - Seeking Alpha
10-Q: NAVIDEA BIOPHARMACEUTICALS, INC. 2:09 p.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Navidea Biopharmaceuticals (NAVB) CEO Mark Pykett on Q1 2014 Results - Earnings Call Transcript 1:04 p.m. May 7, 2014 - Seeking Alpha
Navidea Biopharmaceuticals (NAVB) Q1 2014 Results - Earnings Call Webcast 8:25 a.m. May 7, 2014 - Seeking Alpha
Notable earnings before Wednesday’s open 5:30 p.m. May 6, 2014 - Seeking Alpha
Navidea Continues To Execute, When Will The Stock Follow? 2:45 a.m. April 9, 2014 - Seeking Alpha
10-K: NAVIDEA BIOPHARMACEUTICALS, INC. 5:02 p.m. March 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Navidea: The Future Of The Company Will Be Borne On The Back Of Lymphoseek 11:17 a.m. March 11, 2014 - Seeking Alpha
Navidea Biopharmaceuticals: 4 Reasons To Buy This $2 Lottery Ticket 11:55 a.m. March 10, 2014 - Seeking Alpha
Navidea Biopharmaceuticals, Inc Management Discusses Q4 2013 Results - Earnings Call Transcript 12:50 p.m. March 6, 2014 - Seeking Alpha
Navidea Biopharmaceuticals Discusses Q4 2013 Results (Webcast) 9:25 a.m. March 6, 2014 - Seeking Alpha
Navidea gets PDUFA date for Lymphoseek sNDA 9:03 a.m. March 5, 2014 - Seeking Alpha
FDA grants priority review for expanded use of Navidea's Lymphoseek 11:28 a.m. Feb. 18, 2014 - Seeking Alpha
Do Away With The Pill-A-Day Biotech Model: Steve Brozak 3:05 p.m. Feb. 7, 2014 - Seeking Alpha
Navidea Biopharma signs first Asian distribution agreement 9:34 a.m. Jan. 7, 2014 - Seeking Alpha
Navidea Biopharmaceuticals Inc. - A Follow Up? 9:02 a.m. Dec. 24, 2013 - Seeking Alpha
Navidea Biopharmaceuticals talks MAA for Lymphoseek, shares slide 2:14 p.m. Dec. 20, 2013 - Seeking Alpha

Navidea Biopharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference 7:31 a.m. May 29, 2014 - BusinessWire - BZX
Navidea Announces Eleven Scientific Presentations of Results from Lymphoseek® and Manocept™ Studies at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 7:31 a.m. May 20, 2014 - BusinessWire - BZX
Navidea Announces Restructuring of Pipeline Development 4:32 p.m. May 15, 2014 - GlobeNewswire
Technical Data on Biotech Equities -- Research on Navidea Biopharma, MiMedx, Organovo Holdings, and Raptor Pharma 11:10 a.m. May 14, 2014 - PR Newswire - PRF
Navidea Biopharmaceuticals to Announce First Quarter 2014 Financial Results on May 7, 2014 12:25 p.m. April 29, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Provides Progress Updates on Lymphoseek® Programs 5:31 p.m. April 17, 2014 - BusinessWire - BZX
Navidea Pharmaceuticals Inc. Analyst Report: Long Term Market Potential of Lymphoseek does not Justify Current Valuation by BrokerBank Securities, Inc. 7:00 a.m. April 11, 2014 - PR Newswire - PRF
Navidea Announces Presentation of Study Findings of Manocept™ Platform Imaging Agent in Kaposi Sarcoma at AACR Annual Meeting 7:31 a.m. April 10, 2014 - BusinessWire - BZX
Navidea Announces Presentations Highlighting NAV4694 Beta-Amyloid, PET Imaging Agent at the German Society of Nuclear Medicine Congress 7:31 a.m. March 26, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Provides Update on European Marketing Authorization Application for Lymphoseek® 5:31 p.m. March 19, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Three-Year Recurrence and Survival Outcomes after Sentinel Lymph Node Biopsy in Patients with Breast Cancer and Melanoma 7:31 a.m. March 14, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Closes $30 Million Loan with Oxford Finance, LLC 8:01 a.m. March 6, 2014 - BusinessWire - BZX
Navidea Announces Acceptance for Review of an Additional sNDA to Further Expand Lymphoseek® Labeling 8:30 a.m. March 5, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals to Announce Fourth Quarter and Full-Year 2013 Financial Results on Thursday, March 6, 2014 3:19 p.m. March 3, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Adds New Member to Board of Directors 8:30 a.m. Feb. 19, 2014 - BusinessWire - BZX
Navidea Announces Priority Review for the sNDA to Expand Lymphoseek® Labeling for Sentinel Lymph Node Detection in Patients with Head and Neck Cancer 8:31 a.m. Feb. 18, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Announces the Presentation of Manocept™ Data at Keystone Symposia for Molecular Cell Biology of Macrophages in Human Disease 8:31 a.m. Feb. 13, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Announces Positive Initial Results in Single-Center Cohort from Phase 2b Trial of NAV4694 in Subjects with Mild Cognitive Impairment (MCI) 10:16 a.m. Feb. 6, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals to Present at the 16th Annual BIO CEO and Investor Conference 1:33 p.m. Feb. 4, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals to Present at 2014 Biotech Showcase(TM) Conference 3:59 p.m. Jan. 7, 2014 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Netcapital's 28.62% Plunge: A Fraudulent Drama Unfolds

Netcapital: The Plunge Heard 'Round the Market There it is, clear as day—Netcapital’s (NASDAQ: NCPL) stock plummeting 28.62% like a lead balloon. Shareholders had to watch in horror as pieces of their investments seemed to evaporate, all thanks to a swirl of alleged fraud. You can't just shrug off accusations that a company you've betted on has been cooking its books,...

Veterans, Lawmakers Forge Paths in Spokane Forum

Spokane Forum Sparks Action for Veterans' Policies Gonzaga University turned into a powerhouse of dialogue and determination as the Wounded Warrior Project (WWP) gathered over 145 veterans, elected officials, and advocate groups to hash out critical policy priorities. We're talking high-stakes discussions with real consequences, not just some feel-good meet-up. A...

AI Innovation Incubator Shakes Up Shanghai's Lingang

Incubator Conference Lights Up Lingang Hold onto your hats, folks! Shanghai's Lingang Center is buzzing with activity as the 'World Top-performing Incubator Conference 2026' kicks off. Taking place from October 26 to 28, this gathering isn't just another run-of-the-mill tech meet-up. Oh no, it's about redefining how we talk about innovation, incubation, and the future,...

BETR Faces Shareholder Suit After Plummeting Stock

Better Home & Finance Navigates Turbulent Waters Not every day the news comes up smelling of roses, and that's putting it lightly for Better Home & Finance, trading as NASDAQ: BETR. When you're talking about a splash that sends shockwaves, losing over 28% of your stock value on a single trading day is one whale of a splash indeed. The Numbers That Shook the Waters It's no...

Big Tree Cloud Files Annual Report, Eyes AI Expansion

Annual Reports and Long-Term Vision God, does the stock market love itself some annual filings. Anyway, Big Tree Cloud Holdings Limited (NASDAQ: DSY) just went and did their annual rigmarole with the 20-F form for the fiscal year ending June 2026. Filed with the SEC, they're letting shareholders and the interested masses know—plainly, and probably...

Surgery Partners Buyout: Fair Deal or Insider Jackpot?

What's Going On With Surgery Partners? Alright, here's the scoop that shareholders can't ignore—Surgery Partners (NYSE:SGRY) could be heading under the scalpel itself with a proposed buyout by HealthSpan. For those holding onto SGRY stock, this might feel like watching the rerun of a medical drama where the ending ain't clear yet. Shareholders are set to get $23.50 a...

Abu Dhabi's Youth Orchestra: A Cultural Revolution

A New Dawn for Abu Dhabi's Musical Future Abu Dhabi's making some noise, and I don't mean just any kind of noise. We're talking about a symphony of opportunity. The Department of Culture and Tourism – Abu Dhabi just dropped big news—setting up a dedicated institution for the Youth Orchestra Abu Dhabi. This ain't just a pat on the cultural back; it's a whole new ball...

Pacsun Finds Gear: 177% Sales Surge at F1 Austin!

New Heights in Trackside Fashion Well, it looks like Pacsun's got a knack for making the Austin F1 scene as thrilling as the race itself, weaving fashion into the high-speed atmosphere. This year's Formula 1 United States Grand Prix in Austin brought a whopping 19% sales swell in 2026, marking a total sales increase of 177% since their initial 2023 Austin pop-up. Talk...

ConsensusAI by IDMEXPRESS: A New Era for Course Reviews

Revolutionizing Course Quality Reviews Well, look who decided to shake things up in the world of higher education! IDMEXPRESS has rolled out a tool called ConsensusAI, aimed squarely at transforming how colleges and universities handle course quality reviews. The announcement hit the streets on October 26, 2026, leaving education stakeholders both curious and intrigued....

NOTHING NINE's Global Ambitions: Paris Show's Impact

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...